Yokenella regensburgei -Past, Present and Future.
Dan Alexandru TocCarmen CostacheVlad Sever NeculicioiuIrina-Maria RusuBogdan-Valentin RoznovanAlexandru BotanAdelina Georgiana TocPavel SchiopuPaul-Stefan PanaitescuAdrian Gabriel PanăIoana Alina ColosiPublished in: Antibiotics (Basel, Switzerland) (2024)
Yokenella regensburgei is a Gram-negative rod part of the Enterobacteriaceae family (order Enterobacterales ) and a rare cause of human infections. Although improved diagnostic methods have led to an increase in reports of this elusive pathogen, information remains limited. In order to provide a better understanding of this bacterium, we developed the first comprehensive review of its biology, biochemical profile, antimicrobial resistance pattern, virulence factors, natural reservoir and involvement in various veterinary and human infections. Human infections with this bacterium are scarcely reported, most probably due to constraints regarding its identification and biochemical similarities to Hafnia alvei . Multiple systematic searches revealed 23 cases of human infection, with a seemingly worldwide distribution, mostly in middle-aged or elderly male patients, often associated with immunosuppression. To date, Y. regensburgei has been reported in skin and soft tissue infections, bacteremia and sepsis, osteoarticular infections and in others such as urinary tract and digestive infections. The unique ability of Y. regensburgei to degrade polystyrene presents a novel and promising avenue for addressing plastic pollution in the near future. However, large-scale applications of this bacterium will undoubtedly increase human exposure, highlighting the necessity for comprehensive research into its role in human and veterinary infections, pathogenicity and antibiotic resistance.
Keyphrases
- endothelial cells
- induced pluripotent stem cells
- antimicrobial resistance
- pluripotent stem cells
- middle aged
- multidrug resistant
- soft tissue
- escherichia coli
- risk assessment
- intensive care unit
- acute kidney injury
- healthcare
- end stage renal disease
- climate change
- air pollution
- klebsiella pneumoniae
- patient reported outcomes